ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BLTE vs MRK // ENTERPRISE SCALE & MARKET CAP

Belite Bio Inc (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BLTE 0 — MRK 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
market-cap
$366.03B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLTE VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BLTE MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -15.90% 20.70% -36.60 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield -0.61% 3.42% -4.03 MRK /fcf-yield <GO>
Operating Margin — 34.30% — TIE /operating-margins <GO>
Net Profit Margin — 28.10% — TIE /net-margins <GO>
Revenue Growth (YoY) — 1.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.0 54.3 -5.30 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $6.19B $366.03B -$359.84B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BLTE REV MRK REV BLTE GROSS % MRK GROSS % BLTE FCF MRK FCF
FY 2025 $235.8M $65.01B — 74.8% -$37.1M $12.36B
FY 2024 $112.0M $64.17B — 76.3% -$29.4M $18.10B
FY 2023 $88.7M $60.12B — — -$29.8M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLTE // BETA —
MRK // BETA 0.92